Atlas Trials

Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets

Clinical trial NCT04386915 · UNKNOWN

Trial details

NCT number
NCT04386915
Sponsor
Fujian Cosunter Pharmaceutical Co. Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatitis B
Start date
2020-05-18
Primary completion
2021-05-30
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.